Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weitz

Showing results (541-550 of 3,839) with videos related to

Pageof 384
Sort By:
Expert Opinion on Investigational Drugs|April 23, 2004
Ximelagatran: the first oral direct thrombin inhibitorMark A Crowther, Jeffrey I Weitz
Annual Review of Medicine|January 22, 2005
New anticoagulant therapyLori-Ann Linkins, Jeffrey I Weitz
Trends in Biochemical Sciences|July 9, 2004
Dealing with mechanics: mechanisms of force transduction in cellsPaul A Janmey, David A Weitz
Circulation|July 27, 2005
Coagulation assaysShannon M Bates, Jeffrey I Weitz
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2008
The soft framework of the cellular machineD A Weitz, P A Janmey
Physical Review. B, Condensed Matter|April 1, 1988
Optical properties of aggregate clustersChen, Sheng, Weitz, et al.
Physical Review. A, Atomic, Molecular, and Optical Physics|February 15, 1990
Universal reaction-limited colloid aggregationLin, Lindsay, Weitz, et al.
Ecology Letters|April 29, 2006
Size and scaling of predator-prey dynamicsJoshua S Weitz, Simon A Levin
British Journal of Haematology|June 29, 2006
The status of new anticoagulantsShannon M Bates, Jeffrey I Weitz
Expert Opinion on Investigational Drugs|February 17, 2007
Beyond heparin and warfarin: the new generation of anticoagulantsJeffrey I Weitz, Lori-Ann Linkins
Pageof 384

Showing results (541-550 of 3,839) with videos related to

Sort By:
Pageof 384
Expert Opinion on Investigational Drugs|April 23, 2004
Ximelagatran: the first oral direct thrombin inhibitorMark A Crowther, Jeffrey I Weitz
Annual Review of Medicine|January 22, 2005
New anticoagulant therapyLori-Ann Linkins, Jeffrey I Weitz
Trends in Biochemical Sciences|July 9, 2004
Dealing with mechanics: mechanisms of force transduction in cellsPaul A Janmey, David A Weitz
Circulation|July 27, 2005
Coagulation assaysShannon M Bates, Jeffrey I Weitz
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2008
The soft framework of the cellular machineD A Weitz, P A Janmey
Physical Review. B, Condensed Matter|April 1, 1988
Optical properties of aggregate clustersChen, Sheng, Weitz, et al.
Physical Review. A, Atomic, Molecular, and Optical Physics|February 15, 1990
Universal reaction-limited colloid aggregationLin, Lindsay, Weitz, et al.
Ecology Letters|April 29, 2006
Size and scaling of predator-prey dynamicsJoshua S Weitz, Simon A Levin
British Journal of Haematology|June 29, 2006
The status of new anticoagulantsShannon M Bates, Jeffrey I Weitz
Expert Opinion on Investigational Drugs|February 17, 2007
Beyond heparin and warfarin: the new generation of anticoagulantsJeffrey I Weitz, Lori-Ann Linkins
Pageof 384